Juneko Grilley-Olson

8PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Robert L Ferris, Rom S Leidner, Christine H Chung

|Dec 05, 2024
Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted Therapy.

Rani Bansal, Tolulope Adeyelu, Andrew Elliott

|Oct 04, 2022
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.

Cherie-Ann O Nathan, D Neil Hayes, Theodore Karrison

|Feb 09, 2022
Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.

Ian E Krop, Opeyemi A Jegede, Juneko E Grilley-Olson

|Oct 25, 2021
Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration.

Siwen Hu-Lieskovan, Fadi Braiteh, Juneko E Grilley-Olson

|May 09, 2020
A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma.

Sant P Chawla, Sanjay Goel, Warren Chow

Pageof 2

Frequent Collaborators

2 joint publications

D Neil Hayes

2 joint publications

Jeffrey Chou

1 joint publications

Allison M Deal

1 joint publications

Colette J Shen